ХОНДМАНН Дёрк (US),ВАН ТОЛЬ Эрик А.Ф. (NL),ГРОСС Габриэле (NL),ШОЭМАКЕР Марьеке Х. (NL),ЛАМБЕРС Теартсе Тим (NL)
申请号：
RU2015139557
公开号：
RU2015139557A
申请日:
2014.03.11
申请国别(地区):
RU
年份:
2017
代理人:
摘要：
The present disclosure provides a method for reducing the risk of autoimmune disease by administering a composition comprising peptides selected from a casein hydrolysate. Such a composition, may reduce the symptoms of autoimmune disease and may be a treatment for autoimmune disease, especially type 1 diabetes. Preferably, the hydrolysate consists of peptides with a molecular weight of more than 500 Da.
